News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Why 2017 Will be a Data-Rich and Not Revenue-Focused Year for bluebird bio (BLUE)     2/24/2017
Massachusetts' Agenus (AGEN) Quietly Discloses Failure of Cancer Vaccine Trial     2/22/2017
New FDA Report Cites 22 Drugs That Passed Phase II But Crashed and Burned in Phase III     2/8/2017
No Looking Back: Cellectis (CLLS) Preps for Cutting-Edge 'Off-the-Shelf' CAR-T Trial     2/7/2017
AstraZeneca PLC (AZN) Quietly Kills Some Programs     2/6/2017
3rd Stemline (STML) Patient Died in Clinical Trial One Day Before $45 Million Public Offering     2/3/2017
Why This Big Biotech Could be Biogen (BIIB)'s Downfall     2/3/2017
Bay Area's Calithera Biosciences (CALA) Rockets After Getting $53 Million Upfront in Cancer Deal With Incyte (INCY)     1/31/2017
Tiny Boston Biotech Pieris Nabs $570 Million+ Cancer Deal With French Powerhouse Servier     1/6/2017
Fortress Biotech (FBIO) Surged After Reporting Big Success With CAR-T Cancer Approach     12/30/2016
Cambridge Biotech TCR2 Therapeutics Launches From Stealth Mode With $44.5 Million     12/8/2016
The Franchise That Could Bring in Another $20 Billion for Celgene (CELG)     11/23/2016
Gilead (GILD) Suffers Another R&D Setback as Myelofibrosis Drug Flops in Phase III, Gives Credence to Acquisition Urgency     11/18/2016
China Takes Lead in CRISPR Race, Will Test on a Human for the First Time     11/16/2016
Little-Known Ganymed Grabs a $1.4 Billion Buyout Deal From Astellas (ALPMY)     10/31/2016

News from Around the Web
Could Marijuana Be the Next Miracle Drug For Treating Cancer?     2/20/2017
Could A Little Bit Of Fasting Bring A Lot Of Health Benefits? University of Southern California Study     2/17/2017
GW Pharma (GWPH) Is Set To Benefit As Cannabis Takes On Cancer     2/10/2017
Man Who Took Magic Mushrooms Said It Helped Him See A Basic Truth About Relationships     2/6/2017
Aspen Pharmacare's Old Cancer Drug Gets 1,227% Price Hike In Frugal U.K.     1/30/2017
Breath Test Could Help Detect Stomach And Esophageal Cancers, Imperial College London Study     1/30/2017
Scientists Highlight the Hopes and Fears of Cellectis (ALCLS)' CAR-T     1/26/2017
Novartis AG (NVS) Shows Off 13 Potential Blockbusters in Pipeline     1/25/2017
Dying From Cancer: Where You Live Could Determine Your Fate, University of North Carolina Study Reveals     1/25/2017
5 Stupendously Expensive Cancer Drugs     1/23/2017
5 Major Cancer Studies That Are Proving Difficult To Reproduce, Center For Open Science Reveals     1/20/2017
Nutella Fights Back Against Cancer Scare Concerns     1/13/2017
JPM17: Kite Pharma (KITE)'s Strategy for Commercializing Its Lead CAR-T Drug     1/12/2017
Why I'm Wary Of GRAIL And Its Plan To Develop A Cancer Blood Test     1/9/2017
Liquid Biopsy For Lung Cancer Provides Rapid Results At Low Cost And No Trauma, Stanford University Study     1/6/2017

Press Releases
The World's Richest Doctor's New Cancer Vaccine and NantKwest's Science     2/23/2017
CBT Pharma Presents Data Demonstrating Anti-Tumor Activity Of Its Programmed Death-1 Antibody, CBT-501, At ASCO-SITC Clinical Oncology Symposium     2/23/2017
Children’s National Health System Experts To Present Data On Novel Approach To Cell Therapy For Cancer Patients     2/23/2017
MabSpace Biosciences To Present Preclinical Data On Second Generation PD-L1 Antibody With pH-Dependent Antigen Binding Property At Upcoming Inaugural ASCO-SITC Clinical Immuno-Oncology Symposium     2/23/2017
Bellicum (BLCM) Presents Updated Clinical Results At 2017 BMT Tandem Meetings On BPX-501 In Orphan Inherited Blood Disorders And Hematologic Cancers     2/23/2017
Celltrion Healthcare (068270.KQ) Release: Truxima, The First Biosimilar Mab In Oncology, Granted EU Marketing Authorization     2/22/2017
Atreca Presents New Preclinical Findings For Novel Cancer Immunotherapy Platform At Molecular Medicine Tri-Conference 2017     2/22/2017
NeuroVive (NVP) Appoints Recognized Scientific Advisors And Enters Research Agreements In NASH And Hepatocellular Carcinoma     2/22/2017
Helix Biopharma (TSX:HBP) Release: 30 Million CAD$ Investment In European Centre Of Cancer Immunotherapy     2/22/2017
Cue BioPharma Strengthens Scientific And Clinical Advisory Board With Leading Oncology And Immunology Experts     2/22/2017
Touchstone Innovations Plc Portfolio Company Cell Medica Granted FDA Fast Track Designation For Lead Oncology Product     2/21/2017
Bellicum (BLCM) Announces Initiation Of Patient Dosing With Controllable CAR T-Cell Product Candidate     2/21/2017
Selexis SA Inks Agreement For Applications In Cancer And Infectious Disease     2/21/2017
PetLife Pharma Taps National Public Relations Firm To Help Bring To Market Cancer Treatment Originally Developed By Cuba     2/21/2017
OSE Immunotherapeutics New Immune Checkpoint Inhibitor OSE-172 (Effi-DEM) At The 24th Molecular Med TRI-CON 2017 Meeting Session "Cancer Immunotherapy"     2/21/2017

//-->